Trials / Completed
CompletedNCT02034604
Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 194 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate efficacy and safety of naftopidil in patient with neurogenic lower urinary tract dysfunction not caused by benign prostatic hyperplasia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naftofidil | |
| DRUG | Tamsulosin |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2016-12-01
- Completion
- 2017-08-01
- First posted
- 2014-01-13
- Last updated
- 2019-12-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02034604. Inclusion in this directory is not an endorsement.